37 results
8-K
EX-99.1
ASRT
Assertio Holdings Inc
11 Mar 24
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
5:07pm
in Indocin and Cambia following their respective generic entrants were partially offset by the addition of Rolvedon.
▪Rolvedon net product sales were
8-K
EX-99
ASRT
Assertio Holdings Inc
8 Nov 23
Assertio Reports Third Quarter 2023 Financial Results
4:03pm
increased from $34.3 million to $35.1 million year over year.
▪The addition of Rolvedon and Sympazan sales in the current period were mostly offset … notes, partially offset by interest income of $0.6 million and $1.7 million, respectively, recognized in Other gain (loss) related to the Company’s
8-K
EX-99.1
02dnbizcz
3 Aug 23
Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum Acquisition
4:08pm
424B3
u5bej 5hh4mgfwvibz8
15 Jun 23
Prospectus supplement
4:23pm
425
hpbp9zef
9 May 23
Business combination disclosure
5:10pm
425
EX-99.1
okzqqcq fppg3p
9 May 23
Business combination disclosure
7:16am
8-K
EX-99.1
sai v90t1nrm61is
9 May 23
Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook
7:15am
8-K
EX-99.1
ijmanj8a
8 Nov 22
Assertio Reports Third Quarter 2022 Financial Results
4:45pm
8-K
EX-99.1
jm8dxcxoirmoxcj13a4
9 May 22
Assertio Reports First Quarter 2022 Financial Results
12:00am